2021 Walk4MD Wrap-Up
Thanks to the dedicated teams and participants who registered and fundraised for The Tenaquip Foundation Walk4MD, as well as the amazing donors, sponsors, and research champions, this year’s event was a huge success!
As of today, Muscular Dystrophy Canada (MDC) has exceeded their fundraising goal and reached a total of $925, 158.28 with donations still coming in! The funds raised will be instrumental to delivering MDC’s basket of programs and services, funding life-changing equipment and technologies, investing in translational and clinical research, supporting next-generation clinicians and scientists, increasing education and awareness, influencing positive change, providing emotional support to those affected by NMD… and more.
This year, MDC focused their signature Walk event on research – in addition to a selected Research Champions Team, over 100 clinicians, researchers and students participated. The feedback from our community on the enhanced focus on research has been so positive.
If you missed the virtual event on Saturday, you can watch the replay here:
French: https://youtu.be/-cTGtzfMoT8
English: https://youtu.be/CWrInr5yL5g
Read next...
A Milestone in Neuromuscular Care: AGAMREE® (vamorolone) Approved as the First Treatment for Duchenne Muscular Dystrophy in Canada
Health Canada has approved AGAMREE® (vamorolone), the first-ever treatment for Duchenne Muscular Dystrophy (DMD) in Canada. Patient Support Program opens for enrollment on October 10, 2025.
New Best Practice Recommendations for SBMA Care in Canada
Congratulations to Dr. Kerri Schellenberg, the team of Canadian experts, NMD4C Steering Committee members and Investigators, on publishing the first Canadian SBMA care guidelines!
Advancing Neuromuscular Research and Care: Highlights from the 2025 NMD4C Annual Meeting
On September 11, NMD4C hosted its 2025 Annual Meeting in Ottawa, bringing together clinicians, researchers, trainees, and partners for a full day of collaboration, strategic dialogue, and community-building.
NMD4C Hosts Inaugural Clinical Summer School to Empower Canada’s Future Neuromuscular Leaders
On September 10–11, NMD4C hosted its inaugural Clinical Summer School in Ottawa, bringing together 19 neuromuscular clinical fellows from across Canada for two days of hands-on training, mentorship, and networking. Led by national experts and co-chaired by Drs. Gordon Jewitt and Marianne Nury, the program complemented NMD4C’s accredited lecture series and fostered peer connection through dedicated community-building sessions.
2026 Neuromuscular Postdoctoral Research Fellowships Funding Competition is Now Open!
Apply Or Share this opportunity with the trainees in your network — Deadline: October 14, 2025. Hosted by Neuromuscular Disease Network for Canada (NMD4C) and Muscular Dystrophy Canada (MDC)
Announcing the 2026 Neuromuscular Clinical Fellowship Award Recipients
We are excited to share that the 2026 Neuromuscular Clinical Fellowship Awards have been awarded! These fellowships strengthen clinical training in neuromuscular medicine and help prepare the next generation of specialists who will advance neuromuscular care across Canada.